JP2005154442A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005154442A5 JP2005154442A5 JP2004335711A JP2004335711A JP2005154442A5 JP 2005154442 A5 JP2005154442 A5 JP 2005154442A5 JP 2004335711 A JP2004335711 A JP 2004335711A JP 2004335711 A JP2004335711 A JP 2004335711A JP 2005154442 A5 JP2005154442 A5 JP 2005154442A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- pharmaceutically acceptable
- acceptable salt
- valsartan
- converting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT002267A ITMI20032267A1 (it) | 2003-11-21 | 2003-11-21 | Procdimento per la preparzione di valsartan e suoi intermedi |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005154442A JP2005154442A (ja) | 2005-06-16 |
JP2005154442A5 true JP2005154442A5 (ja) | 2007-12-20 |
Family
ID=34430775
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004335711A Pending JP2005154442A (ja) | 2003-11-21 | 2004-11-19 | バルサルタンおよびその中間体を調製する方法 |
Country Status (8)
Country | Link |
---|---|
US (1) | US7439261B2 (ja) |
EP (1) | EP1533305B1 (ja) |
JP (1) | JP2005154442A (ja) |
AT (1) | ATE386027T1 (ja) |
DE (1) | DE602004011730D1 (ja) |
ES (1) | ES2300692T3 (ja) |
IT (1) | ITMI20032267A1 (ja) |
PT (1) | PT1533305E (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0514206D0 (en) | 2005-07-11 | 2005-08-17 | Novartis Ag | Organic compounds |
EP1764365A1 (en) | 2005-09-20 | 2007-03-21 | KRKA, D.D., Novo Mesto | A process for the preparation of sartan derivates and intermediates useful in such process |
ES2288376B1 (es) * | 2005-10-20 | 2008-11-01 | Inke, S.A. | Procedimiento para la obtencion de intermedios utiles en la obtencion de un compuesto farmaceuticamente activo. |
ES2316281B1 (es) * | 2007-05-14 | 2010-02-09 | Quimica Sintetica, S.A. | Procedimiento para la preparacion de valsartan. |
EP2316821A1 (en) * | 2009-10-27 | 2011-05-04 | Novartis AG | Process for the manufacture of organic compounds |
MX2013001251A (es) * | 2010-08-03 | 2013-03-18 | Novartis Ag | Valsartan altamente cristalino. |
EP2902385B1 (en) * | 2012-09-26 | 2019-01-09 | API Corporation | Deprotection method for tetrazole compound |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE122010000024I1 (de) * | 1990-02-19 | 2010-07-08 | Novartis Ag | Acylverbindungen |
US6869970B2 (en) * | 2002-02-04 | 2005-03-22 | Novartis Ag | Crystalline salt forms of valsartan |
-
2003
- 2003-11-21 IT IT002267A patent/ITMI20032267A1/it unknown
-
2004
- 2004-11-12 EP EP04026903A patent/EP1533305B1/en not_active Revoked
- 2004-11-12 AT AT04026903T patent/ATE386027T1/de not_active IP Right Cessation
- 2004-11-12 PT PT04026903T patent/PT1533305E/pt unknown
- 2004-11-12 DE DE602004011730T patent/DE602004011730D1/de active Active
- 2004-11-12 ES ES04026903T patent/ES2300692T3/es active Active
- 2004-11-19 JP JP2004335711A patent/JP2005154442A/ja active Pending
- 2004-11-19 US US10/991,431 patent/US7439261B2/en not_active Expired - Fee Related